1.Individualized therapy is the future of diagnosis and treatment for colorectal cancer.
Chinese Journal of Gastrointestinal Surgery 2012;15(1):1-3
Colorectal cancer has become one of the most common malignant tumors that affects Chinese's health. Recurrence and metastasis are main reasons for death of colorectal cancer patients. Making up individualized and comprehensive therapeutic strategy according to patients' specific matters is the developmental direction of diagnosis and treatment for colorectal cancer. Only if standardize clinical pathway, perfect postoperative follow-up system, and accelerate research development on biomarkers, individualized therapy of colorectal cancer can be accomplished.
Colorectal Neoplasms
;
diagnosis
;
surgery
;
therapy
;
Humans
;
Precision Medicine
5.Three generations of a family allergic to vitamin C.
Chinese Journal of Pediatrics 2003;41(9):651-651
Ascorbic Acid
;
adverse effects
;
immunology
;
Child, Preschool
;
Drug Hypersensitivity
;
etiology
;
Family
;
Female
;
Humans
;
Male
6.Role of Nrf2/Keap1/ARE signaling pathway in respiratory diseases
Chinese Pharmacological Bulletin 2015;(11):1488-1492
Nrf2/Keap1/ARE is an important signaling pathway in maintaining the balance between peroxide and antioxidants. Once oxidative stress happened, Nrf2/Keap1/ARE would be ac-tivated to regulate the expression of downstream antioxidant pro-teins that could reduce the injury from oxidative stress and the level of oxidative stress. Recent researches show that Nrf2/Keap1/ARE signaling pathway is closely related to refractory re-spiratory diseases such as pulmonary fibrosis (PF), lung canc-er, chronic obstructive pulmonary disease (COPD), suggesting that Nrf2/Keap1/ARE signaling pathway may be a potential ther-apeutic target. This review focuses on the role of Nrf2/Keap1/ARE signaling pathway in refractory respiratory diseases in order to further understand the related mechanism and provide evidence for the diagnosis and treatment of refractory respiratory diseases.
10.Current status of the treatment of colorectal cancer in China--development and limitations.
Chinese Journal of Gastrointestinal Surgery 2012;15(10):989-992
There is a significant gap between China and the optimal international level in terms of the treatment outcomes of colorectal cancer. In recent years, progresses have been made while limitations still exist in the management of colorectal cancer. Advances are seen including use of multi-disciplinary therapy, neoadjuvant chemoradiation, laparoscopic surgery and management of liver metastasis. Individualized therapy is also applied in colorectal cancer. However, randomized controlled trials based on Chinese population are still lacking. Radiation therapy is inadequate and standardization of surgical technique is to be improved. Although standardization of management of colorectal cancer has gained attention from the government, there is a long way to go. The establishment of subspecialty training and practice has not been satisfactory. National efforts are needed to improve the treatment outcomes of colorectal cancer in China.
China
;
Colorectal Neoplasms
;
therapy
;
Humans
;
Laparoscopy
;
Liver Neoplasms
;
Neoadjuvant Therapy
;
Treatment Outcome